Renal papillary necrosis (RPN) is a signi cant problem in human beings, especially in England and in Australia where it has been reported to account for 15% to 20% of patients needing renal transplants. Many compounds , including aspirin, phenacetin, phenylbutazone , indomethacin, mefenamic acid, ufenamic acid, fenopro n, naproxen, and ibuprofen have been linked to renal papillary necrosis in human beings. Although the exact mechanism of RPN is unknown, there are several theories that have good scienti c evidence behind them. Study of RPN in animals as models for the disease in human beings is limited by several factors, including anatomical differences between human beings and most animal species as well as technical dif culties in studying the renal papilla.
Renal papillary necrosis (RPN) was originally described in diabetic patients, and is also associated with urinary tract obstruction and infection. However, it is most commonly associated with analgesic drug abuse, especially with the nonsteroidal, anti-in ammatory drugs (1, 2) . Analgesicinduced RPN is more common in Australia and England and less common in the United States. In Australia, it has been reported to account for between 15% and 20% of patients needing renal transplants (3, 4) . It is more common in women than men. This probably re ects a physiologi c difference, because female rats are more susceptible to the disease (1, 4, 5) .
The literature concerning analgesic-induced RPN is confusing at best, contradictory at worst. Phenacetin, the rst compound identi ed to cause RPN, was subsequently removed from many over-the-counter medications (1, 3) . The case for aspirin is more uncertain; aspirin is included in the list of agents reported to cause RPN in animals and is linked to cases in people, but others have reported that it is difcult to produce RPN in animals with aspirin alone. One report showed that aspirin combined with phenacetin caused RPN in animals, but when aspirin, phenacetin, and caffeine in combination were studied in a 2-year NTP study, no evidence of RPN was observed (6, 7, 8, 9) . Other compounds that have been reported to cause RPN include amidopyrine and phenazone (which are not used today because of toxicity), phenylbutazone, indomethacin, mefenamic acid, ufenamic acid, fenopro n, naproxen, ibuprofen, and numerous others. Most published reports indicate that acetaminophen alone does not cause RPN (2, 8) .
Normally, NSAIDs have little effect on the human kidney. However, in the presence of volume depletion (for example, due to diuretics or congestive heart failure), underlying renal disease, or long-term analgesic abuse, RPN may occur (10, 11) . The incidence and/or severity of RPN has been shown to increase when analgesics are taken in combination, or when a patient is dehydrated (1) .
Diagnosis of analgesic-induced RPN in people is dif cult in the early stages of the disease because there are few speci c symptoms during this time. The earliest symptoms may include headaches and upper gastrointestinal disorder. Later clinical signs and symptoms include nocturia, dysuria, bacteriuria, pyuria, microscopic hematuria, ureteral colic, and lower back pain. Clinical pathology may reveal decreased glomerular ltration rate, increased blood urea nitrogen, and renal tubular acidosis. Later in the course of the disease, hypertension, cardiac disease, peripheral vascular disease, renal calculi, and bladder stones may occur (1) . Pyelonephritis is a hallmark of RPN. The eventual outcome in a human being or animal that survives is chronic renal failure and uremia (12) .
Renal papillary necrosis can be dif cult to diagnose with radiology if the necrosed papilla remains in place, but the use of computerized tomography and ultrasound has increased diagnostic sensitivity (1) . Magnetic resonance microscopy has been used experimentally but it is technically dif cult (1, 13) .
The pathologic changes of analgesic-induced RPN have been studied at the light and electron microscopic levels. The typical sequence of events after exposure to low doses of analgesics was degeneration of interstitial cells, evidenced by cytoplasmic edema, dilation of organelles, and increased proteoglycan production, followed by damage to the endothelial cells and loops of Henle. Platelet thrombi occur, and tubular lumens ll with cellular debris (14) . Experimentally, the rst of these changes is visible by electron microscopy 1 to 4 hours after dosing with bromoethylamine (BEA), and with light microscopy after 4 hours (14) .
Other studies, done using a single large dose of either BEA or diphenylamine, reported the rst changes were those in the endothelial cells, and not in interstitial cells as discussed before (15) (16) (17) . When lower doses of BEA were used, endothelial damage or microvascular leakage damage occurred later in the course of the disease (1). Either way, these changes led to tubular and glomerular damage, followed by calci cation, brosis, or sloughing of the renal papilla and in some cases, urothelial hyperplasia or neoplasia (8, 14, 18) .
The mechanism of RPN due to analgesics is not completely understood, and the literature reports several different, welldocumented theories. One possible mechanism is a direct toxic effect on cells in the medulla. The initial target in analgesic nephropathy may be the medullary interstitial cell, as previously mentioned (1, 14, 19) . Toxic effects to the interstitial cells could come about from reactive intermediates, acetylation of critical cellular proteins, or inhibition of cellular functions (8, 20) . Because medullary interstitial cells synthesize both prostaglandins and proteoglycans, damage to these cells could lead to many effects, including changes in the matrix and effects on the vasculature. Changes in the interstitial matrix would affect the kidneys' ability to concentrate urine, one of the earliest signs of RPN (19) .
A second possible mechanism is ischemic injury through the direct inhibition of cyclooxygenase-mediated production of prostaglandins. Two different isoforms of cyclooxygenase (COX) have been shown to exist. Most NSAIDs are nonselective inhibitors of both isoforms of COX genes. It has been postulated that this inhibition may lead to the side effects of NSAIDs, including RPN. Cox I is expressed in high levels in the collecting ducts and renal vasculature, and in a small number of papillary interstitial cells of rats, nonhuman primates, and humans. Cox II is present in the papillary interstitial cells of rats and dogs, but not in nonhuman primates or humans. Cox II, unlike Cox I, is induced by in ammation (11, 21) . Differences in the susceptibility of humans and laboratory animals to NSAIDs may be related to their differences in expressions of COX genes (11) .
Regardless of whether the mechanism is interstitial cell necrosis or cyclo-oxygenase inhibition, the end result is decreased prostaglandin production. This leads to decreased vascular perfusion, vasoconstriction, and eventually to ischemic necrosis.
It has also been reported that ischemia occurs in RPN as a result of direct endothelial cell damage (15) , especially after a large, single dose of chemical. This situation is less likely to mimic long-term analgesic abuse in human beings, but may more accurately re ect changes that occur following a single large ingestion of analgesics, as may occur in an intentional overdose.
Most likely there are several different mechanisms that could cause RPN, depending on the speci c agent, the dose, and the species.
Eventually, with long-term abuse of NSAIDs, urothelial carcinomas may develop. Phenylbutazone caused hyperplasia and transitional cell carcinomas in the renal pelvis in female rats in a chronic NTP study (22) . The mechanism of tumor induction was unclear. It may be that chronic in ammation and necrosis lead to neoplasia. In many human patients that died with carcinoma of the renal pelvis, there was evidence of renal papillary necrosis adjacent to the tumor (3) . It is also possible that metabolites of NSAIDs may be carcinogenic. Phenacetin, which is an aromatic amide, may act as a tumor promoter and has been shown to induce chromosomal aberrations in vivo. Metabolites of phenacetin are closely related to carcinogenic amines like the naphthylamines that caused occupational cancer (4, 18) .
Despite the widespread use of NSAIDs and the prevalence of RPN, there is a paucity of good animal models with which to study the disease. RPN has been reported in horses, dogs, cats, mice, rats, gerbils, hamsters, rabbits, desert mice, primates, and pigs. Of those species listed, the pig is the only one that, like human beings, has up to 20 papillae in each kidney; the rest have a single papilla per kidney (1) . Furthermore, NSAIDs are not the only drugs known to cause RPN. For example, much of the experimental evidence related to the pathogenesis of RPN has been obtained through studies with BEA or diphenylamine, 2 compounds that are structurally and chemically distinct from NSAIDs, and whose mechanistic effects may not exactly mimic those of NSAIDs. It is likely that RPN is a common endpoint of several different mechanistic pathways, rather than a distinct pathognomonic change.
A further complication is the technical dif culty in handling and processing the renal papilla, to ensure its availability for pathological evaluation. For example, the small size of a rat or mouse kidney and the small amount of tissue in the renal papilla make in vivo assessment of renal papillary disease dif cult. Hedlund et al (13) reported using magnetic resonance microscopy to evaluate the damage caused to rat kidneys by BEA. With this technique, they were able to detect damage in the outer, but not the inner medulla (13) . As new techniques emerge and older ones become re ned, the ability to assess papillary lesions in live animals will become easier, and may lead to a better understanding of renal papillary necrosis in humans.
